Study suggests when to bypass a bypass
Eight million Americans suffer from a condition called lower extremity peripheral arterial disease. The sickest of them are crippled by the narrowing of arteries in their legs. Bypass surgery, which uses grafts—vessels from elsewhere in the patient's body—to reroute blood, can be an effective treatment. But for some patients, postsurgery complications, such as a blocked graft, can lead to pain or even a leg or foot amputation. So surgeons would like to have a way to predict which patients are at highest risk of these unfortunate outcomes.
Traits: A recent study offers some guidelines. Led by DMS vascular surgeon Philip Goodney, M.D., the study pinpointed patient traits suggesting that surgery could lead to complications. "We tried to pick out the preoperative patient traits that might help us to predict, on an individual patient basis, what the likelihood of [a blockage or amputation] is," Goodney says.
Goodney and his colleagues reviewed 2,306 lower extremity bypass procedures performed at 11 hospitals in northern New England, including DHMC, from 2003 through 2007. The study, published in Annals of Vascular Surgery, found that in 277 of the cases, the graft became blocked within one year of the operation. Some of the graft occlusions led to amputation of the patient's foot or leg. Other patients didn't suffer blocked grafts but still required an amputation, usually because of complications such as a foot infection or wound. Overall, 143 amputations were performed within a year, most of them—83%—as a result of a clogged graft.
Proxy: The researchers identified eight risk factors. For example, patients who experienced occlusion or amputation tended to be less than 50 years old. Goodney believes this relative youth is a proxy for patients who were heavy smokers and had other medical problems. Other presurgery risk factors include being unable to walk independently, living in a nursing home, requiring dialysis, having critical limb ischemia (severe artery blockage), needing venovenostomy (a bypass that requires several veins sutured together), and needing surgery with a tarsal target (that is, connecting to very tiny arteries in the foot).
Patients with several risk factors might consider alternatives.
Goodney says patients flagged with several of these traits "might, unfortunately, consider alternatives other than bypass surgery." Current alternatives include angioplasty, which flattens plaque against artery walls. New therapies, now in clinical trials, seek to grow new blood vessels through genetic manipulation. Ongoing research is examining the effectiveness of these alternatives.
Awry: The researchers were surprised by how frequently bypass surgery—the "gold standard" for treating severe arterial disease—could go awry, says Goodney. The finding "will help surgeons choose their patients more effectively [and] allows us to compare risk-adjusted results across surgeons, so that we can find out who's doing things well, and then study . . . what it is that they do well."
If you'd like to offer feedback about these articles, we'd welcome getting your comments at DartMed@Dartmouth.edu.
These articles may not be reproduced or reposted without permission. To inquire about permission, contact DartMed@Dartmouth.edu.